Codexis
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2002Stage
PIPE | IPOTotal Raised
$92MMarket Cap
0.57BStock Price
8.62About Codexis
Codexis discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services.
Codexis Headquarter Location
200 Penobscot Drive
Redwood City, California, 94063,
United States
650-421-8100
Expert Collections containing Codexis
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Codexis is included in 3 Expert Collections, including Synthetic Biology.
Synthetic Biology
305 items
Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.
Advanced Materials
1,256 items
Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.
Drug Discovery Tech Market Map
220 items
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.
Codexis Patents
Codexis has filed 472 patents.
The 3 most popular patent topics include:
- Molecular biology
- RNA
- EC 1.1.1
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
3/26/2020 | 8/2/2022 | Molecular biology, EC 3.4.21, Rare diseases, Proteins, Protein families | Grant |
Application Date | 3/26/2020 |
---|---|
Grant Date | 8/2/2022 |
Title | |
Related Topics | Molecular biology, EC 3.4.21, Rare diseases, Proteins, Protein families |
Status | Grant |
Latest Codexis News
Aug 9, 2022
The post Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis appeared first on iSelect Fund.
Codexis Web Traffic
Codexis Rank
When was Codexis founded?
Codexis was founded in 2002.
Where is Codexis's headquarters?
Codexis's headquarters is located at 200 Penobscot Drive, Redwood City.
What is Codexis's latest funding round?
Codexis's latest funding round is PIPE.
How much did Codexis raise?
Codexis raised a total of $92M.
Who are the investors of Codexis?
Investors of Codexis include Casdin Capital, Shell, Chevron Technology Ventures, Presidio Partners, Pequot Venture Capital and 5 more.
Who are Codexis's competitors?
Competitors of Codexis include Viridos, Enerkem, Allozymes, Biomatter Designs, Erbi Biosystems and 13 more.
You May Also Like

Viridos is dedicated to developing and commercializing genomic-driven solutions to address global energy and environmental challenges. The company's main research and business programs are focused on the following major bioenergy areas: designing advanced biofuels with superior properties compared to ethanol and biodiesel; harnessing photosynthetic organisms to produce value-added products directly from sunlight and carbon dioxide; developing new biological solutions to increase production and/or recovery rates of subsurface hydrocarbons and developing high-yielding, more disease resistant and economic feedstocks. It was founded in 2005 and is based in La Jolla, California.

Erbi Biosystems is developing systems to automate the study of microorganisms for basic research and bioprocess characterization and optimization. Through microfluidics and integration, large scale bioreactors can be miniaturized to the milliliter scale, enabling greatly reduced volumes in addition to automated control.
WHEB Biofuels Limited aims to be a biofuels producer that also invests in biofuels technologies
Biodiesel Technologies offers biodiesel processor equipment
Greenline Industries manufactures biodiesel production equipment.
Formed as Malibu Capital Partners, Inc., Altra has been in the business of acquiring and developing a portfolio of renewable energy projects throughout the United States specifically focused on the production and sale of ethanol and biodiesel. Altra aims to become the leading integrated biofuels company in the U.S., employing state-of-the-art manufacturing facilities, processing technologies and customer service disciplines, and positioned as a critical biofuels supplier to petroleum companies and other significant end-users in all key geographic markets.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.